Press release
Specificity (OTCQB: SPTY) Signs LOI with Blackpearl - Global Push to End $250B Ad Tech Fraud - More Stocks Inside
Specificity Inc. (OTCQB: SPTY), a next-generation ad tech company redefining precision digital marketing, announced it has signed a Letter of Intent (LOI) with Blackpearl Group (NZX: BPG) to build the world's first fully integrated ad tech stack - a breakthrough designed to directly confront the estimated $250 billion in annual digital ad fraud that continues to drain the global advertising industry.The partnership will combine Specificity's proprietary audience-targeting platform with Blackpearl's advanced AI-driven Private Data Platform, capable of processing more than 21 billion verified data signals per day. Together, the companies aim to create a secure, fraud-resistant, end-to-end marketing ecosystem that ensures advertisers reach real people - not bots.
"This partnership represents a seismic shift in digital marketing," said Jason Wood, Founder and Chairman of Specificity. "For the first time, we control the entire data pipeline - from capture to activation - allowing us to deliver precision, transparency, and accountability unmatched by Big Tech."
7 Undervalued Stocks to Watch now in addition to Specificity Inc. (OTCQB: SPTY): Intensity Therapeutics, Inc. (NASDAQ: INTS), Harvard Bioscience Inc (NASDAQ: HBIO), Karbon-X Corp (OTCQX: KARX), Jiuzi Holdings Inc (NASDAQ: JZXN), Incannex Healthcare Ltd (NASDAQ: IXHL), CPI Aerostructures Inc (NYSE: CVU) and watch Signal Advance, Inc. (OTCID: SIGL) mentioned alongside Wallstreet Elite International Business Machines Corporation (NYSE: IBM) as all trading actively in early trading sessions are currently.
Under the leadership of CEO Robert Fedder, a 30-year technology veteran formerly with HP Inc. (NYSE: HPQ), Vodafone Group PLC (NASDAQ: VOD), and Telefonica SA (NYSE: TEF), Specificity continues to scale rapidly as it executes on its mission to eliminate wasted ad spend and restore trust in digital advertising.
Chief Technology Officer Rob Gagne, who previously led engineering initiatives at J.P. Morgan Chase & Co. (NYSE: JPM), Hyatt Hotels Corporation (NYSE: H), Jefferies Financial Group Inc. (NYSE: JEF), and Toyota Motor Corporation (NYSE: TM), will oversee the integration of advanced machine learning to detect and eliminate fraudulent and mechanical traffic at scale - setting a new global benchmark for verified human engagement.
Blackpearl Group (NZX: BPG), a data intelligence and AI technology company founded in 2012 and headquartered in Wellington, New Zealand, specializes in scalable infrastructure, behavioral analytics, and data enrichment for the U.S. market. By pairing Blackpearl's enterprise-grade data architecture with Specificity's proprietary human-verification and audience-targeting engine, the two companies are poised to eradicate systemic ad tech inefficiencies that have cost brands billions in fake impressions and bot-driven traffic.
Together, Specificity (SPTY) and Blackpearl Group (BPG) are building a next-generation ad tech ecosystem where transparency, verified engagement, and measurable ROI define success. Their alliance is more than a partnership-it's a direct assault on the $250 billion global ad fraud crisis, setting the stage for the world's first fully accountable, fraud-free digital marketing environment.
With its growing leadership team, expanding partnerships, and breakthrough technology, Specificity (SPTY) is rapidly emerging as a transformative force positioned to redefine the economics of digital marketing worldwide.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=specificity-otcqb-spty-signs-loi-with-blackpearl-global-push-to-end-250b-ad-tech-fraud-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Specificity (OTCQB: SPTY) Signs LOI with Blackpearl - Global Push to End $250B Ad Tech Fraud - More Stocks Inside here
News-ID: 4247466 • Views: …
More Releases from ABNewswire
CoreAge Rx Raises the Bar on Medication Delivery With Free 2-Day Shipping, Tempe …
As GLP-1 demand continues to grow across the United States, CoreAge Rx delivers compounded Semaglutide and Tirzepatide directly to patients' doors with speed, discretion, and pharmaceutical-grade handling at no extra cost.
Image: https://www.abnewswire.com/upload/2026/02/97f63fd2a72edd923f925e1750cfbd14.jpg
CoreAge Rx, a LegitScript-certified telehealth weight management provider based in Wichita Falls, Texas, has built a medication delivery model that independent reviewers and patients consistently describe as one of the strongest in the GLP-1 telehealth space. Free 2-day shipping…
CoreAge Rx Builds Its GLP-1 Program Around Patient Support That Goes Beyond the …
With 24/7 access, rapid response times, dedicated care coordinators, and physician continuity throughout treatment, CoreAge Rx has set a new standard for what patient support looks like in telehealth weight management.
Image: https://www.abnewswire.com/upload/2026/02/79b953c7d7b86bdc830623292680666e.jpg
CoreAge Rx, a LegitScript-certified telehealth weight management provider based in Wichita Falls, Texas, has built a patient support model that independent reviewers consistently identify as one of the most comprehensive in the GLP-1 telehealth space. From 24/7 access across…
Healthy for Wellness Has Given an In-Depth Analysis of Why CoreAge Rx Is Better …
Image: https://www.abnewswire.com/upload/2026/02/850d8bbc779e7d12fe40cc6941e07be3.jpg
Healthy for Wellness has published an in-depth analysis [https://healthyforwellness.com/healthy-for-wellness-has-given-an-in-depth-analysis-of-why-coreage-rx-is-better-than-its-competitors/]examining why CoreAge Rx stands out within the growing GLP-1 prescription weight management space. The review evaluates the company's physician-supervised structure, telehealth-based accessibility, compounded GLP-1 medication program, and patient-centered model in comparison to other providers operating in the same category.
CoreAge Rx [https://www.coreagerx.com/] operates as a prescription-based telehealth program that provides compounded GLP-1 medications for eligible adults seeking medically supervised weight management…
Healingxchange Spotlights CoreAge Rx as the Best GLP-1 Brand in the World, Citin …
Independent health platform credits CoreAge Rx's patient-centered approach, compounded GLP-1 therapies, and transparent pricing structure starting at $99 per month as the defining factors behind its top recognition
Image: https://www.abnewswire.com/upload/2026/02/7b94f9d607ddfdff3120e3788650d497.jpg
Healingxchange, an independent health and wellness platform, has published [https://www.healingxchange.com/meet-coreage-rx-the-best-glp-1-brand-in-the-world/] a featured review recognizing CoreAge Rx as the best GLP-1 brand in the world. The full article is available at www.healingxchange.com [http://www.healingxchange.com/]. The recognition follows a detailed editorial assessment of CoreAge Rx's…
More Releases for Specificity
TCR Therapy Pipeline Insight 2025: Targeting Intracellular Tumor Antigens with U …
T-cell receptor (TCR) therapy represents a next-generation cell-based immunotherapy that unlocks access to intracellular tumor antigens presented via MHC molecules, overcoming limitations of conventional CAR-T therapies. TCR therapies are gaining momentum, particularly for solid tumors, by enabling antigen-specific immune responses that are tailored to a patient's unique HLA profile. DelveInsight's "TCR Therapy - Pipeline Insight, 2025" analyzes over 55 pipeline candidates under active clinical development, focusing on high-value targets such…
Engineering Multivalent Antibodies for Specificity and Potency
The engineering of multivalent antibodies represents a cutting-edge approach in the development of highly specific and potent therapeutics. These antibodies, designed to bind multiple antigens or epitopes simultaneously, offer significant advantages over traditional monoclonal antibodies, providing enhanced efficacy and reducing the likelihood of resistance. The focus on specificity and potency in multivalent antibody design opens new avenues for treating complex diseases, particularly in oncology, infectious diseases, and autoimmune disorders.
Download Bispecific,…
Global Dual Specificity Protein Kinase TTK Market Forecast 2019-2026
Global Dual Specificity Protein Kinase TTK Market: Overview
The Global Dual Specificity Protein Kinase TTK Market is one of the fastest growing markets nowadays. It has shown good growth in previous few years. The global Dual Specificity Protein Kinase TTK market is anticipated to show more growth in the future. Dual Specificity Protein Kinase TTK market report provides you depth knowledge about the Dual Specificity Protein Kinase TTK market studies findings…
Product Specificity Analysis: Upgradation in Lifestyles of Individuals Through P …
Developments in modern societies encourage a focus on the needs and goals of the individual. Product Specificity is a counter-trend amid the near-ubiquitous mass-market products and brands, and consumers are looking for more bespoke, personalized products and services. Designing these products and services is beneficial for both consumers and manufacturers, leading to higher consumer satisfaction and product/brand loyalty.
Product Specificity is one of the 63 trends that has been covered as…
Tyrosine Kinase Inhibitors Market: Specificity and Efficacy to Boost Adoption
Cancer is the unregulated growth of body cells due to genetic mutations in its differentiation regulatory genes. Tyrosine kinases are enzymes that signal the cell differentiation cycle, mutation in their expression genes leads to their over expression, which results in uncontrolled proliferation of cells to form tumors. To comprehend recent trends, factors that are influencing growth of global tyrosine kinase inhibitors market, Market Research Hub (MRH) has included a report…
Trend Sights Analysis: Product Specificity Addressing The Consumer Need To Share …
Summary
A counter-trend amid the ubiquity of mass-market products and brands is the search for more bespoke, personalized products and services. "Mass customization" is being adopted as consumer-facing companies seek to capitalize on demand for greater product variety and individualization. Products that meet more personal needs are perceived as offering superior value.
Key Findings
"Just-for-me" product solutions appeal to today's self-expressive and individualistic consumers who reject a "one-size-fits-all" approach to consumption/usage of products.…
